Cybulskiego 30, 50-205 Wroclaw
Poland						                            
                            
						
 Research Article
												Demethylation with 5-Aza-2²-deoxycytidine Affects Oxidative Metabolism in Human and Mouse Non-small Cell Lung Cancer Cells 						
Author(s): Agnieszka  J Sok, Agnieszka  Gizak, Piotr  Mamczur, Aleksandra  Piotrowska, Agata  Knapik, Jerzy  Kolodziej, Piotr Dziegiel, Jacek R Wisniewski and Dariusz  RakusAgnieszka  J Sok, Agnieszka  Gizak, Piotr  Mamczur, Aleksandra  Piotrowska, Agata  Knapik, Jerzy  Kolodziej, Piotr Dziegiel, Jacek R Wisniewski and Dariusz  Rakus             
						
												
				 Background: Non-small cell lung cancer is the most common cause of death from cancer in the world. Here we demonstrate the effect of 5-aza-2’-deoxycytidine (5-dAza), which is one of the most promising anticancer drugs, on the growth and metabolism of mouse (KLN205) and human non-small cell lung cancer-derived (hNSCLC) cells.
Results: In both cell lines we observed reduction of the cells viability and rate of their proliferation after 5-dAza treatment. These changes correlated with the lowering of ATP synthesis and lactate release from cells and with overproduction of reactive oxygen species. 5-dAza-treatment of lung cancer cells also induced a decrease of mitochondrial membrane potential and damage of mitochondrial network. These changes were partially reversed by rotenone treatme.. Read More»
				  
												DOI:
												 10.4172/1948-5956.1000246 
																	  
Cancer Science & Therapy received 5332 citations as per Google Scholar report